Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Phase III OLYMPUS and ROCKIES trials for roxadustat met their primary endpoints in chronic kidney disease patients with anaemia
-
Bevespi Aerosphere approved in the EU for chronic obstructive pulmonary disease
-
Lynparza meets primary endpoint in Phase III SOLO-3 trial for the treatment of relapsed BRCA-mutated advanced ovarian cancer
-
Lynparza approved by US FDA for 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer
-
Roxadustat approved in China for the treatment of anaemia in chronic kidney disease patients on dialysis
-
AstraZeneca and Cancer Research UK launch Functional Genomics Centre to accelerate the discovery of new medicines
-
Update on the Phase III EAGLE trial of Imfinzi and tremelimumab in advanced head and neck cancer
-
New long-term data on Calquence presented at ASH 2018
-
AstraZeneca presents clinical research advances for blood cancer patients at 2018 American Society of Hematology Annual Meeting
-
US FDA grants Fasenra Orphan Drug Designation for Eosinophilic Granulomatosis with Polyangiitis
Latest articles and press releases
All of our latest press releases and articles are available to explore
